Professor Tony Freemont
Head of School of Biomedicine (to 30 June 2011); Head of Undergraduate Medical Education (from 1 July 2011)
Professor Tony Freemont is Head of School of Biomedicine (to 30 June 2011); Head of Undergraduate Medical Education (from 1 July 2011).
The School of Biomedicine incorporates research groups in:
- Cardiovascular
- Developmental Biomedicine
He is also Lead Pathologist in Osteoarticular Pathology and Deputy Director (Medical) for the Division of Laboratory Medicine in Central Manchester and Manchester Childrens' University NHS Trust (CMMC), Non-Executive Director of the Christie NHS Trust, chairing the committee monitoring Clinical and Research Governance, Chair of the Examiners in Histopathology for the Royal College of Pathologists and a member of the PMETB/MMC committee on assessments.
Funded by the Research Councils, NHS and a number of research charities, he holds research grant income of about £1.5 million. He authored or co-authored more than 200 peer reviewed publications, over 50 reviews, approximately 30 chapters, and a book. I have supervised 34 MD/PhD students. I am a member of the College of Experts of the MRC and editorial board member of 4 journals.
Research interests
Professor Freemont's research falls into two distinct areas:
- Primary research (basic molecular pathology and regenerative medicine)
Currently, his primary research focuses on identifying molecular mechanisms underlying discogenic low back pain and designing novel therapies using regenerative medicine techniques (eg tissue engineering, stem cell manipulation, gene therapy).
- Clinical practice-based research (primarily diagnostics)
In his role as Professor of Osteoarticular Pathology, he has been responsible for changing clinical practice through:- Defining the impact of adynamic bone disease in renal failure patients and reclassifying renal osteodystrophy to facilitate clinical decision-making.
- Defining the scope of synovial fluid microscopy in early management of arthritis.
Related links